PMA device
Urologix Targis System
Urologix, LLC · System, Hyperthermia, Rf/Microwave (Benign Prostatic Hyperplasia),Thermotherapy (MEQ, Class III) · First FDA decision Mar 2, 2000, newest Oct 29, 2015Enlarged prostate (BPH)
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
16
PMA pathway
Device trials
0
Naming "Urologix Targis"
MAUDE reports
0
Brand "Urologix Targis", since 2015
PubMed studies
0
Mentioning "Urologix Targis"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Urologix Targis System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 16 decisions filed under this name.
- UROLOGIX TARGIS SYSTEMPMA supplement
P970008-S065 · Decided Oct 29, 2015 · 49 days after receipt · Normal 180 Day Track No User Fee
Device type: System, hyperthermia, rf/microwave (benign prostatic hyperplasia),thermotherapy (MEQ) · GI, Urology & Nephrology
- UROLOGIX TARGIS SYSTEMPMA supplement
P970008-S058 · Decided Dec 9, 2011 · 161 days after receipt · Normal 180 Day Track
Device type: System, hyperthermia, rf/microwave (benign prostatic hyperplasia),thermotherapy (MEQ) · GI, Urology & Nephrology
- UROLOGIX TARGIS SYSTEMPMA supplement
P970008-S038 · Decided Sep 2, 2008 · 176 days after receipt · Normal 180 Day Track
Device type: System, hyperthermia, rf/microwave (benign prostatic hyperplasia),thermotherapy (MEQ) · GI, Urology & Nephrology
3 more FDA decisions with a free account
Older decisions: P970008-S026, P970008-S024, P970008-S023, P970008-S021, P970008-S019, P970008-S018, P970008-S016, P970008-S015, P970008-S014, P970008-S013
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Urologix Targis", any status and sponsor, newest update first.
No registered device study names "Urologix Targis".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Urologix Targis", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code MEQ
3 reports: 1 malfunction, 2 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2710-2011 · Started Apr 28, 2011 · Posted by FDA Jun 30, 2011
Reason given: Urologix is recalling certain lots of Targis System Coolant Bag devices distributed over a two week period. The devices are packaged into disposable Procedure Kits containing a microwave catheter, a Coolant Bag and a RTU Plus balloon. The reason for this Recall involves three lots of Coolant Bags that contain an...
Cause as FDA categorized it: Nonconforming Material/Component · Device type: System, Hyperthermia, Rf/Microwave (Benign Prostatic Hyperplasia),Thermotherapy (MEQ)
Z-1174-2010 · Started Feb 18, 2010 · Posted by FDA Mar 19, 2010
Reason given: Urolgix is recalling certain lots of CTC Advance" catheters and RTU Plus devices which are integral components of the Targis System. The reason for this Recall is a labeling error only; the issue involves a discrepancy in the"Use Before" date printed on the product label. In the affected lots, the "Use Before" date ,...
Cause as FDA categorized it: Incorrect or no expiration date · Device type: System, Hyperthermia, Rf/Microwave (Benign Prostatic Hyperplasia),Thermotherapy (MEQ)
Z-0720-2007 · Started Mar 16, 2007 · Posted by FDA Apr 5, 2007
Reason given: The catheter in the kit matches the description on the kit and pouch label; however, an incorrect label was placed onto the catheter during manufacturing.
Cause as FDA categorized it: Other · Device type: System, Hyperthermia, Rf/Microwave (Benign Prostatic Hyperplasia),Thermotherapy (MEQ)
1 more recall records with a free account
Published research
The most relevant PubMed records for "Urologix Targis"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code MEQ.
- Prolieve Thermodilatation SystemMedifocus, Inc. · PMA 2007
- TMX-2000 BphBoston Scientific Corp · PMA 2004
- Prostalund Coretherm System and Prostaland Coretherm AccessoriesProstalund AB · PMA 2014
- Prolieve Thermodilitation SystemMedifocus, Inc. · PMA 2011
- Coretherm System Microwave ThermotherapyProstalund AB · PMA 2009
- ProstatronUrologix, Inc. · PMA 2005
- Prolieve Thermodilation SystemMedifocus, Inc. · PMA 2018
- Urologix Prostatron SystemUrologix, Inc. · PMA 2008
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.